Christine Fu
- Ophthalmology top 5%
- Glaucoma and retinal disorders 5
-
- Axon Guidance and Neuronal Signaling 4
- Pharmacology top 10%
- Flavonoids in Medical Research 3
- Parasitology top 10%
-
- CAR-T cell therapy research 14
-
- Lymphoma Diagnosis and Treatment 3
-
- Viral Infectious Diseases and Gene Expression in Insects 2
- Retinal Development and Disorders 2
-
- Acute Lymphoblastic Leukemia research 2
- Co-authors
- David W. SretavanJohn F. BechbergerMark A. OzogChristian C. NausBernard PerbalTony TranJiulin DuDoo Hun Lim
- Journals
- Journal of Biological Chemistry (1 paper)Journal of Clinical Oncology (1 paper)Journal of Neuroscience (1 paper)
- Partner nations
- United StatesCanadaTürkiye
In The Last Decade
Christine Fu
28 papers receiving 635 citations
Peers
Comparison fields: 5 of 81
- Ophthalmology 122
- Cellular and Molecular Neuroscience 120
- Developmental Neuroscience 26
- Pharmacology 50
- Parasitology 34
Countries citing papers authored by Christine Fu
This map shows the geographic impact of Christine Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Fu more than expected).
Fields of papers citing papers by Christine Fu
This network shows the impact of papers produced by Christine Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Fu. The network helps show where Christine Fu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christine Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 9 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 8 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 1 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 2 | |
| 13 | 2012 | 26 | |
| 14 | 2011 | 18 | |
| 15 | 2010 | 65 | |
| 16 | 2007 | 11 | |
| 17 | 2007 | 54 | |
| 18 | 2007 | 28 | |
| 19 | 2005 | 79 | |
| 20 | 2004 | 137 |
About Christine Fu
Christine Fu is a scholar working on Ophthalmology, Oncology and Cellular and Molecular Neuroscience, having authored 29 papers that have together received 648 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Glaucoma and retinal disorders (5 papers), Axon Guidance and Neuronal Signaling (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Flavonoids in Medical Research (3 papers), Viral Infectious Diseases and Gene Expression in Insects (2 papers), Retinal Development and Disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Ophthalmology (122 citations), Cellular and Molecular Neuroscience (120 citations) and Developmental Neuroscience (26 citations). Christine Fu has collaborated with scholars based in United States, Canada and Türkiye. Frequent co-authors include David W. Sretavan, John F. Bechberger, Mark A. Ozog, Christian C. Naus, Bernard Perbal, Tony Tran, Jiulin Du, Doo Hun Lim, Janet Koprivnikar and Kathrin Klein. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Journal of Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.